Get the Stockscreener App
1.68
1.75%
-0.03
After Hours:
1.68
60 Degrees Pharmaceuticals Inc stock is traded at $1.68, with a volume of 30,575.
It is down -1.75% in the last 24 hours and up +18.31% over the past month.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. Currently, company's pipeline under development covers development programs for vector-borne, fungal, and viral diseases utilizing three of the Company's future products: (i) new products that contain the Arakoda regimen of Tafenoquine; (ii) new products that contain Tafenoquine; and (iii) Celgosivir and/or botanical extracts from Australian Chestnut Trees.
See More
Previous Close:
$1.71
Open:
$1.69
24h Volume:
30,575
Relative Volume:
0.21
Market Cap:
$4.47M
Revenue:
$1.31M
Net Income/Loss:
$-7.56M
P/E Ratio:
-0.1632
EPS:
-10.2926
Net Cash Flow:
$-8.25M
1W Performance:
-5.62%
1M Performance:
+18.31%
6M Performance:
-18.46%
1Y Performance:
-82.35%
1-Day Range:
$1.68
$1.7799
1-Week Range:
$1.66
$1.92
52-Week Range:
$1.22
$10.77
60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile
Name
60 Degrees Pharmaceuticals Inc
Sector
Industry
Phone
202-327-5422
Address
1025 CONNECTICUT AVENUE NW, WASHINGTON
Compare SXTP vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SXTP
60 Degrees Pharmaceuticals Inc
|
1.68 | 4.68M | 1.31M | -7.56M | -8.25M | -10.29 |
VRTX
Vertex Pharmaceuticals Inc
|
529.59 | 126.07B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
649.81 | 65.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
916.80 | 57.70B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
313.04 | 40.19B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.99 | 39.82B | 742.00K | -1.37B | -1.07B | -7.0731 |
60 Degrees Pharmaceuticals Inc Stock (SXTP) Latest News
60 Degrees Pharmaceuticals, Inc. Warranton 60 Degrees Ph Financial Disclosures & SEC Filings - TradingView
60 Degrees Pharma babesiosis study clears safety review By Investing.com - Investing.com Nigeria
Safety board backs 60 Degrees Pharma's babesiosis trial continuation - Stock Titan
SXTP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SXTP Forecast — Price Target — Prediction for 2027 - TradingView
60 Degrees Pharmaceuticals, Inc. Actuals & Estimates (BOATS:SXTP) - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Valuation: PE, PB & Fair Value Analysis - TradingKey
Price to book forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Price to sales forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Enterprise value to EBIT forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
Enterprise value to revenue forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
60 Degrees Pharmaceuticals Inc (SXTP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Number of shareholders of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView
SXTP News | 60 DEGREES PHARMA INC (NASDAQ:SXTP) - ChartMill
60 Degrees Pharmaceuticals Inc (SXTP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Institutional Confidence - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
60 Degrees Pharmaceuticals Inc - TradingKey
60 Degrees Pharmaceuticals Inc (SXTP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Institutional Confidence - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Valuation: PE, PB & Fair Value Analysis - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
60 Degrees Pharmaceuticals Inc (SXTPW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Top Executive Makes Bold Move With Fresh Buy in Pharma Stock - TipRanks
Insider Buying: Geoffrey Dow Acquires Additional Shares of 60 De - GuruFocus
60 degrees pharmaceuticals CEO buys $10,131 in stock By Investing.com - Investing.com South Africa
60 degrees pharmaceuticals CEO buys $10,131 in stock - Investing.com
Insider Purchase: President and CEO of $SXTP Buys 7,350 Shares - Moomoo
CEO Geoffrey Dow adds 7,350 SXTP shares in open-market buy - Stock Titan
60 Degrees Pharmaceuticals Licenses Patent to Produce Australian Chestnut Extract - marketscreener.com
60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement - The Manila Times
60 Degrees Pharmaceuticals (SXTP) proposes 800K-share equity refresh, reverse split - Stock Titan
60 Degrees details tafenoquine priority review voucher strategy - The Globe and Mail
According to a document submitted to the U.S. Securities and Exchange Commission, the biopharmaceutical company 60 Degrees Pharmaceuticals, Inc. may submit a New Drug Application for its drug tafenoquine to the U.S. Food and Drug Administration bef - Bitget
60 Degrees Pharmaceuticals to seek Priority Review Voucher if tafenoquine trial supports NDA - TradingView
60 Degrees Pharmaceuticals (SXTP) details potential NDA and FDA voucher path - Stock Titan
60 Degrees Pharmaceuticals Q1 2026 Earnings: EPS Falls Sharply Short of Estimates as Development Costs MountDebt Analysis Report - The Legal Advocate
SXTP Q1 2026 Earnings: Significant EPS Miss as Company Continues Pre-Revenue PhaseROE Trend Analysis - The Legal Advocate
60 Degrees Pharm 1Q Rev $162,000 >SXTP - Moomoo
60 Degrees Pharmaceuticals (SXTP) Slips 6% as Shares Test Key SupportNew Highs New Lows - newsline.com
SXTP60 Degrees Pharmaceuticals Inc Stock Price and Quote - Finviz
60 Degrees Pharmaceuticals enrolls first patient in babesiosis trial - Investing.com
60 Degrees Pharmaceuticals enrolls first patient in babesiosis trial By Investing.com - Investing.com Canada
60 Degrees Pharmaceuticals Announces Early Enrollment of - GlobeNewswire
60 Degrees Pharmaceuticals Inc Stock (SXTP) Financials Data
Revenue
Net Income
Cash Flow
EPS
60 Degrees Pharmaceuticals Inc Stock (SXTP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DOW GEOFFREY S | President and CEO |
Dec 15 '25 |
Buy |
0.80 |
9,670 |
7,759 |
59,618 |
| DOW GEOFFREY S | President and CEO |
Dec 10 '25 |
Buy |
0.95 |
9,350 |
8,886 |
46,335 |
| DOW GEOFFREY S | President and CEO |
Dec 11 '25 |
Buy |
0.92 |
3,613 |
3,318 |
49,948 |
0.05%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):